Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin
- 1 January 1982
- journal article
- research article
- Published by Elsevier BV in Metabolic Bone Disease and Related Research
- Vol. 4 (1), 39-42
- https://doi.org/10.1016/0221-8747(82)90007-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- REAPPRAISAL OF PLATEAU PHASE IN MYELOMAThe Lancet, 1980
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980
- Treatment of severe hypecalcaemia with calcitoninMetabolic Bone Disease and Related Research, 1980
- Salmon Calcitonin in the Acute Treatment of Moderate and Severe Hyperealcemia in ManActa Medica Scandinavica, 1978
- Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculatorBlood, 1977
- Prognostic factors in multiple myelomaCancer, 1975
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- The Calcium Lowering Effect of Synthetic Human, Porcine, and Salmon Calcitonin in Patients with Paget's DiseaseClinical Science, 1973
- Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue CultureScience, 1965